Global Senolytic Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 89

Published Date: 30 Jun 2022

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Senolytic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Senolytic Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Retail Pharmacies accounting for % of the Senolytic Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While FOXO4-related Peptides segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Senolytic Drug include AgeX Therapeutics, Inc., Cleara Biotech, Eternans Ltd., FoxBio Inc, and Numeric Biotech, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Senolytic Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
FOXO4-related Peptides
Bcl-2 Family Inhibitors
Navitoclax
Dasatinib and Quercetin
Others

Market segment by Application, can be divided into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

Market segment by players, this report covers
AgeX Therapeutics, Inc.
Cleara Biotech
Eternans Ltd.
FoxBio Inc
Numeric Biotech
T.A. Sciences, Inc.
Recursion Pharmaceuticals, Inc.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Senolytic Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Senolytic Drug, with revenue, gross margin and global market share of Senolytic Drug from 2019 to 2022.
Chapter 3, the Senolytic Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Senolytic Drug market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Senolytic Drug research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Senolytic Drug
    1.2 Classification of Senolytic Drug by Type
        1.2.1 Overview: Global Senolytic Drug Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Senolytic Drug Revenue Market Share by Type in 2021
        1.2.3 FOXO4-related Peptides
        1.2.4 Bcl-2 Family Inhibitors
        1.2.5 Navitoclax
        1.2.6 Dasatinib and Quercetin
        1.2.7 Others
    1.3 Global Senolytic Drug Market by Application
        1.3.1 Overview: Global Senolytic Drug Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Retail Pharmacies
        1.3.3 Hospital Pharmacies
        1.3.4 Online Pharmacies
    1.4 Global Senolytic Drug Market Size & Forecast
    1.5 Global Senolytic Drug Market Size and Forecast by Region
        1.5.1 Global Senolytic Drug Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Senolytic Drug Market Size by Region, (2017-2022)
        1.5.3 North America Senolytic Drug Market Size and Prospect (2017-2028)
        1.5.4 Europe Senolytic Drug Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Senolytic Drug Market Size and Prospect (2017-2028)
        1.5.6 South America Senolytic Drug Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Senolytic Drug Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Senolytic Drug Market Drivers
        1.6.2 Senolytic Drug Market Restraints
        1.6.3 Senolytic Drug Trends Analysis

2 Company Profiles
    2.1 AgeX Therapeutics, Inc.
        2.1.1 AgeX Therapeutics, Inc. Details
        2.1.2 AgeX Therapeutics, Inc. Major Business
        2.1.3 AgeX Therapeutics, Inc. Senolytic Drug Product and Solutions
        2.1.4 AgeX Therapeutics, Inc. Senolytic Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 AgeX Therapeutics, Inc. Recent Developments and Future Plans
    2.2 Cleara Biotech
        2.2.1 Cleara Biotech Details
        2.2.2 Cleara Biotech Major Business
        2.2.3 Cleara Biotech Senolytic Drug Product and Solutions
        2.2.4 Cleara Biotech Senolytic Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Cleara Biotech Recent Developments and Future Plans
    2.3 Eternans Ltd.
        2.3.1 Eternans Ltd. Details
        2.3.2 Eternans Ltd. Major Business
        2.3.3 Eternans Ltd. Senolytic Drug Product and Solutions
        2.3.4 Eternans Ltd. Senolytic Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Eternans Ltd. Recent Developments and Future Plans
    2.4 FoxBio Inc
        2.4.1 FoxBio Inc Details
        2.4.2 FoxBio Inc Major Business
        2.4.3 FoxBio Inc Senolytic Drug Product and Solutions
        2.4.4 FoxBio Inc Senolytic Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 FoxBio Inc Recent Developments and Future Plans
    2.5 Numeric Biotech
        2.5.1 Numeric Biotech Details
        2.5.2 Numeric Biotech Major Business
        2.5.3 Numeric Biotech Senolytic Drug Product and Solutions
        2.5.4 Numeric Biotech Senolytic Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Numeric Biotech Recent Developments and Future Plans
    2.6 T.A. Sciences, Inc.
        2.6.1 T.A. Sciences, Inc. Details
        2.6.2 T.A. Sciences, Inc. Major Business
        2.6.3 T.A. Sciences, Inc. Senolytic Drug Product and Solutions
        2.6.4 T.A. Sciences, Inc. Senolytic Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 T.A. Sciences, Inc. Recent Developments and Future Plans
    2.7 Recursion Pharmaceuticals, Inc.
        2.7.1 Recursion Pharmaceuticals, Inc. Details
        2.7.2 Recursion Pharmaceuticals, Inc. Major Business
        2.7.3 Recursion Pharmaceuticals, Inc. Senolytic Drug Product and Solutions
        2.7.4 Recursion Pharmaceuticals, Inc. Senolytic Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Recursion Pharmaceuticals, Inc. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Senolytic Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Senolytic Drug Players Market Share in 2021
        3.2.2 Top 10 Senolytic Drug Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Senolytic Drug Players Head Office, Products and Services Provided
    3.4 Senolytic Drug Mergers & Acquisitions
    3.5 Senolytic Drug New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Senolytic Drug Revenue and Market Share by Type (2017-2022)
    4.2 Global Senolytic Drug Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Senolytic Drug Revenue Market Share by Application (2017-2022)
    5.2 Global Senolytic Drug Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Senolytic Drug Revenue by Type (2017-2028)
    6.2 North America Senolytic Drug Revenue by Application (2017-2028)
    6.3 North America Senolytic Drug Market Size by Country
        6.3.1 North America Senolytic Drug Revenue by Country (2017-2028)
        6.3.2 United States Senolytic Drug Market Size and Forecast (2017-2028)
        6.3.3 Canada Senolytic Drug Market Size and Forecast (2017-2028)
        6.3.4 Mexico Senolytic Drug Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Senolytic Drug Revenue by Type (2017-2028)
    7.2 Europe Senolytic Drug Revenue by Application (2017-2028)
    7.3 Europe Senolytic Drug Market Size by Country
        7.3.1 Europe Senolytic Drug Revenue by Country (2017-2028)
        7.3.2 Germany Senolytic Drug Market Size and Forecast (2017-2028)
        7.3.3 France Senolytic Drug Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Senolytic Drug Market Size and Forecast (2017-2028)
        7.3.5 Russia Senolytic Drug Market Size and Forecast (2017-2028)
        7.3.6 Italy Senolytic Drug Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Senolytic Drug Revenue by Type (2017-2028)
    8.2 Asia-Pacific Senolytic Drug Revenue by Application (2017-2028)
    8.3 Asia-Pacific Senolytic Drug Market Size by Region
        8.3.1 Asia-Pacific Senolytic Drug Revenue by Region (2017-2028)
        8.3.2 China Senolytic Drug Market Size and Forecast (2017-2028)
        8.3.3 Japan Senolytic Drug Market Size and Forecast (2017-2028)
        8.3.4 South Korea Senolytic Drug Market Size and Forecast (2017-2028)
        8.3.5 India Senolytic Drug Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Senolytic Drug Market Size and Forecast (2017-2028)
        8.3.7 Australia Senolytic Drug Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Senolytic Drug Revenue by Type (2017-2028)
    9.2 South America Senolytic Drug Revenue by Application (2017-2028)
    9.3 South America Senolytic Drug Market Size by Country
        9.3.1 South America Senolytic Drug Revenue by Country (2017-2028)
        9.3.2 Brazil Senolytic Drug Market Size and Forecast (2017-2028)
        9.3.3 Argentina Senolytic Drug Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Senolytic Drug Revenue by Type (2017-2028)
    10.2 Middle East & Africa Senolytic Drug Revenue by Application (2017-2028)
    10.3 Middle East & Africa Senolytic Drug Market Size by Country
        10.3.1 Middle East & Africa Senolytic Drug Revenue by Country (2017-2028)
        10.3.2 Turkey Senolytic Drug Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Senolytic Drug Market Size and Forecast (2017-2028)
        10.3.4 UAE Senolytic Drug Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Senolytic Drug Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Senolytic Drug Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Senolytic Drug Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Senolytic Drug Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Senolytic Drug Revenue Market Share by Region (2023-2028)
    Table 6. AgeX Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors
    Table 7. AgeX Therapeutics, Inc. Major Business
    Table 8. AgeX Therapeutics, Inc. Senolytic Drug Product and Solutions
    Table 9. AgeX Therapeutics, Inc. Senolytic Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Cleara Biotech Corporate Information, Head Office, and Major Competitors
    Table 11. Cleara Biotech Major Business
    Table 12. Cleara Biotech Senolytic Drug Product and Solutions
    Table 13. Cleara Biotech Senolytic Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Eternans Ltd. Corporate Information, Head Office, and Major Competitors
    Table 15. Eternans Ltd. Major Business
    Table 16. Eternans Ltd. Senolytic Drug Product and Solutions
    Table 17. Eternans Ltd. Senolytic Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. FoxBio Inc Corporate Information, Head Office, and Major Competitors
    Table 19. FoxBio Inc Major Business
    Table 20. FoxBio Inc Senolytic Drug Product and Solutions
    Table 21. FoxBio Inc Senolytic Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Numeric Biotech Corporate Information, Head Office, and Major Competitors
    Table 23. Numeric Biotech Major Business
    Table 24. Numeric Biotech Senolytic Drug Product and Solutions
    Table 25. Numeric Biotech Senolytic Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. T.A. Sciences, Inc. Corporate Information, Head Office, and Major Competitors
    Table 27. T.A. Sciences, Inc. Major Business
    Table 28. T.A. Sciences, Inc. Senolytic Drug Product and Solutions
    Table 29. T.A. Sciences, Inc. Senolytic Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Recursion Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
    Table 31. Recursion Pharmaceuticals, Inc. Major Business
    Table 32. Recursion Pharmaceuticals, Inc. Senolytic Drug Product and Solutions
    Table 33. Recursion Pharmaceuticals, Inc. Senolytic Drug Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Global Senolytic Drug Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 35. Global Senolytic Drug Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 36. Breakdown of Senolytic Drug by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 37. Senolytic Drug Players Head Office, Products and Services Provided
    Table 38. Senolytic Drug Mergers & Acquisitions in the Past Five Years
    Table 39. Senolytic Drug New Entrants and Expansion Plans
    Table 40. Global Senolytic Drug Revenue (USD Million) by Type (2017-2022)
    Table 41. Global Senolytic Drug Revenue Share by Type (2017-2022)
    Table 42. Global Senolytic Drug Revenue Forecast by Type (2023-2028)
    Table 43. Global Senolytic Drug Revenue by Application (2017-2022)
    Table 44. Global Senolytic Drug Revenue Forecast by Application (2023-2028)
    Table 45. North America Senolytic Drug Revenue by Type (2017-2022) & (USD Million)
    Table 46. North America Senolytic Drug Revenue by Type (2023-2028) & (USD Million)
    Table 47. North America Senolytic Drug Revenue by Application (2017-2022) & (USD Million)
    Table 48. North America Senolytic Drug Revenue by Application (2023-2028) & (USD Million)
    Table 49. North America Senolytic Drug Revenue by Country (2017-2022) & (USD Million)
    Table 50. North America Senolytic Drug Revenue by Country (2023-2028) & (USD Million)
    Table 51. Europe Senolytic Drug Revenue by Type (2017-2022) & (USD Million)
    Table 52. Europe Senolytic Drug Revenue by Type (2023-2028) & (USD Million)
    Table 53. Europe Senolytic Drug Revenue by Application (2017-2022) & (USD Million)
    Table 54. Europe Senolytic Drug Revenue by Application (2023-2028) & (USD Million)
    Table 55. Europe Senolytic Drug Revenue by Country (2017-2022) & (USD Million)
    Table 56. Europe Senolytic Drug Revenue by Country (2023-2028) & (USD Million)
    Table 57. Asia-Pacific Senolytic Drug Revenue by Type (2017-2022) & (USD Million)
    Table 58. Asia-Pacific Senolytic Drug Revenue by Type (2023-2028) & (USD Million)
    Table 59. Asia-Pacific Senolytic Drug Revenue by Application (2017-2022) & (USD Million)
    Table 60. Asia-Pacific Senolytic Drug Revenue by Application (2023-2028) & (USD Million)
    Table 61. Asia-Pacific Senolytic Drug Revenue by Region (2017-2022) & (USD Million)
    Table 62. Asia-Pacific Senolytic Drug Revenue by Region (2023-2028) & (USD Million)
    Table 63. South America Senolytic Drug Revenue by Type (2017-2022) & (USD Million)
    Table 64. South America Senolytic Drug Revenue by Type (2023-2028) & (USD Million)
    Table 65. South America Senolytic Drug Revenue by Application (2017-2022) & (USD Million)
    Table 66. South America Senolytic Drug Revenue by Application (2023-2028) & (USD Million)
    Table 67. South America Senolytic Drug Revenue by Country (2017-2022) & (USD Million)
    Table 68. South America Senolytic Drug Revenue by Country (2023-2028) & (USD Million)
    Table 69. Middle East & Africa Senolytic Drug Revenue by Type (2017-2022) & (USD Million)
    Table 70. Middle East & Africa Senolytic Drug Revenue by Type (2023-2028) & (USD Million)
    Table 71. Middle East & Africa Senolytic Drug Revenue by Application (2017-2022) & (USD Million)
    Table 72. Middle East & Africa Senolytic Drug Revenue by Application (2023-2028) & (USD Million)
    Table 73. Middle East & Africa Senolytic Drug Revenue by Country (2017-2022) & (USD Million)
    Table 74. Middle East & Africa Senolytic Drug Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Senolytic Drug Picture
    Figure 2. Global Senolytic Drug Revenue Market Share by Type in 2021
    Figure 3. FOXO4-related Peptides
    Figure 4. Bcl-2 Family Inhibitors
    Figure 5. Navitoclax
    Figure 6. Dasatinib and Quercetin
    Figure 7. Others
    Figure 8. Senolytic Drug Revenue Market Share by Application in 2021
    Figure 9. Retail Pharmacies Picture
    Figure 10. Hospital Pharmacies Picture
    Figure 11. Online Pharmacies Picture
    Figure 12. Global Senolytic Drug Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 13. Global Senolytic Drug Revenue and Forecast (2017-2028) & (USD Million)
    Figure 14. Global Senolytic Drug Revenue Market Share by Region (2017-2028)
    Figure 15. Global Senolytic Drug Revenue Market Share by Region in 2021
    Figure 16. North America Senolytic Drug Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Europe Senolytic Drug Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Asia-Pacific Senolytic Drug Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. South America Senolytic Drug Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. Middle East and Africa Senolytic Drug Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 21. Senolytic Drug Market Drivers
    Figure 22. Senolytic Drug Market Restraints
    Figure 23. Senolytic Drug Market Trends
    Figure 24. AgeX Therapeutics, Inc. Recent Developments and Future Plans
    Figure 25. Cleara Biotech Recent Developments and Future Plans
    Figure 26. Eternans Ltd. Recent Developments and Future Plans
    Figure 27. FoxBio Inc Recent Developments and Future Plans
    Figure 28. Numeric Biotech Recent Developments and Future Plans
    Figure 29. T.A. Sciences, Inc. Recent Developments and Future Plans
    Figure 30. Recursion Pharmaceuticals, Inc. Recent Developments and Future Plans
    Figure 31. Global Senolytic Drug Revenue Share by Players in 2021
    Figure 32. Senolytic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 33. Global Top 3 Players Senolytic Drug Revenue Market Share in 2021
    Figure 34. Global Top 10 Players Senolytic Drug Revenue Market Share in 2021
    Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 36. Global Senolytic Drug Revenue Share by Type in 2021
    Figure 37. Global Senolytic Drug Market Share Forecast by Type (2023-2028)
    Figure 38. Global Senolytic Drug Revenue Share by Application in 2021
    Figure 39. Global Senolytic Drug Market Share Forecast by Application (2023-2028)
    Figure 40. North America Senolytic Drug Sales Market Share by Type (2017-2028)
    Figure 41. North America Senolytic Drug Sales Market Share by Application (2017-2028)
    Figure 42. North America Senolytic Drug Revenue Market Share by Country (2017-2028)
    Figure 43. United States Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 44. Canada Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 45. Mexico Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 46. Europe Senolytic Drug Sales Market Share by Type (2017-2028)
    Figure 47. Europe Senolytic Drug Sales Market Share by Application (2017-2028)
    Figure 48. Europe Senolytic Drug Revenue Market Share by Country (2017-2028)
    Figure 49. Germany Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. France Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. United Kingdom Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Russia Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. Italy Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. Asia-Pacific Senolytic Drug Sales Market Share by Type (2017-2028)
    Figure 55. Asia-Pacific Senolytic Drug Sales Market Share by Application (2017-2028)
    Figure 56. Asia-Pacific Senolytic Drug Revenue Market Share by Region (2017-2028)
    Figure 57. China Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Japan Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. South Korea Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. India Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Southeast Asia Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Australia Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. South America Senolytic Drug Sales Market Share by Type (2017-2028)
    Figure 64. South America Senolytic Drug Sales Market Share by Application (2017-2028)
    Figure 65. South America Senolytic Drug Revenue Market Share by Country (2017-2028)
    Figure 66. Brazil Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Argentina Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Middle East and Africa Senolytic Drug Sales Market Share by Type (2017-2028)
    Figure 69. Middle East and Africa Senolytic Drug Sales Market Share by Application (2017-2028)
    Figure 70. Middle East and Africa Senolytic Drug Revenue Market Share by Country (2017-2028)
    Figure 71. Turkey Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 72. Saudi Arabia Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. UAE Senolytic Drug Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Methodology
    Figure 75. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AgeX Therapeutics, Inc.
Cleara Biotech
Eternans Ltd.
FoxBio Inc
Numeric Biotech
T.A. Sciences, Inc.
Recursion Pharmaceuticals, Inc.

Related Reports

Global Senolytic Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Senolytic Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 10 Feb 2023

date Medical Care

According to our (Global Info Research) latest study, the global Senolytic Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Senolytic Drug Supply, Demand and Key Producers, 2023-2029

Global Senolytic Drug Supply, Demand and Key Producers, 2023-2029

date 26 Mar 2023

date Medical Care

The global Senolytic Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Senolytic Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Senolytic Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 30 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Senolytic Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

senolytic drug

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>